{
    "clinical_study": {
        "@rank": "109145", 
        "arm_group": [
            {
                "arm_group_label": "Control", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Vaseline has been used on the first day after laser treatment"
            }, 
            {
                "arm_group_label": "Sunscreen", 
                "arm_group_type": "Active Comparator", 
                "description": "Sunscreen has been used on the first day after laser treatment"
            }
        ], 
        "brief_summary": {
            "textblock": "- The use of sunscreen on the first day after fractional ablative skin resurfacing may\n      reduce the risk of post-inflammatory hyperpigmentation"
        }, 
        "brief_title": "The Use of Sunscreen Starting on the First Day After Ablative Fractional Skin Resurfacing", 
        "completion_date": {
            "#text": "August 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "PIH", 
        "detailed_description": {
            "textblock": "-  The use of sunscreen on the first day after fractional ablative skin resurfacing may\n           reduce the risk of post-inflammatory hyperpigmentation (PIH)\n\n        -  Therefore, we conducted the study to evaluate the efficacy of the use of sunscreen on\n           the first day after fractional ablative skin resurfacing in reducing the risk of PIH."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients who want to receive fractional ablative laser resurfacing for acne scars\n\n        Exclusion Criteria:\n\n          -  Pregnancy\n\n          -  Lactation\n\n          -  Age < 18"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 20, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01756664", 
            "org_study_id": "Siriraj-Eucerin01", 
            "secondary_id": "SI402/2012"
        }, 
        "intervention": [
            {
                "arm_group_label": "Sunscreen", 
                "intervention_name": "Sunscreen", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Control", 
                "intervention_name": "Vaseline", 
                "intervention_type": "Other"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Petrolatum", 
                "Sunscreening Agents"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 26, 2012", 
        "location": {
            "contact": {
                "email": "rungsima.wan@mahidol.ac.th", 
                "last_name": "Rungsima Wanitphakdeedecha, MD"
            }, 
            "facility": {
                "address": {
                    "city": "Bangkok", 
                    "country": "Thailand", 
                    "zip": "10700"
                }, 
                "name": "Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University"
            }, 
            "investigator": {
                "last_name": "Rungsima Wanitphakdeedecha, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Thailand"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Use of Sunscreen Starting on the First Day After Ablative Fractional Skin Resurfacing - A Pilot Study.", 
        "other_outcome": {
            "measure": "Transepidermal Water Loss", 
            "safety_issue": "No", 
            "time_frame": "1 Week"
        }, 
        "overall_contact": {
            "email": "rungsima.wan@mahidol.ac.th", 
            "last_name": "Rungsima Wanitphakdeedecha, MD"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Thailand: Ethical Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Melanin Index", 
            "safety_issue": "No", 
            "time_frame": "3 Month"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01756664"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Erythema Index", 
            "safety_issue": "No", 
            "time_frame": "3 Months"
        }, 
        "source": "Mahidol University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Mahidol University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "August 2012"
    }
}